Switches in the expression and function of PACAP and VIP receptors during phenotypic interconversion in human neuroblastoma cells

Neuropeptides

Volumn 30, Issue 4, 1996, Pages 313-322

  Lelievre V ^a   Becq Giraudon, L ^a   Meunier, A C ^a   Muller, J M ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC GMP; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; NEUROPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL;

EID: 0029741215     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(96)90019-0     Document Type: Article

References (23)

1. Israel MA, Thiele CJ. Tumor cell lines of the peripheral nervous system. In: Hay RJ, Park J-G, Gazdar A, eds. Atlas of Human Tumor Cell Lines. San Diego: Academic Press, 1994: 43-78.
2. Biedler JL, Helson L, Spengler BA. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 1973; 33: 2643-2653.
3. Sadee W, Yu VC, Richards ML et al. Expression of neurotransmitter receptors and myc protooncogenes in subclones of a human neuroblastoma cell line. Cancer Res 1987; 47: 5207-5212.
4. Muller JM, Lolait SJ, Yu VC, Sadee W, Wascheck JA. Functional vasoactive intestinal polypeptide (VIP) receptors in human neuroblastoma subclones that contain VIP precursor mRNA and release VIP-like substances. J Biol Chem 1989; 264: 3647-3650.
5. Waschek JA, Muller JM, Duan DS, Sadee W. Retinoic acid enhances VIP receptor expression and responsiveness in human neuroblastoma cell, SH-SY5Y. FEBS Lett 1989; 250: 611-614.
6. Hoschino M, Li M, Zheng LQ, Suzuki M, Mochizuki T, Yanaihara N. Pituitary adenylate cyclase activating peptide and vasoactive intestinal polypeptide: differentiation effects on human neuroblastoma NB-OK-1 cells. Neurosci Lett 1993; 159: 35-38.
7. 6-dibutyryladenosine 3′,5′-monophosphate, phorbol 12-myristate 13-acetate and by the polypeptide itself in human neuroblastoma cells, IMR-32. Eur J Biochem 1994; 223: 147-153.
8. Gozes I, Brenneman DE. VIP: Molecular biology and neurobiological function. Mol Neurobiol 1989; 3: 201-236.
9. Said SI. Vasoactive intestinal polypeptide. Biologic role in health and disease. Trends Endocrinol Metab 1991; 3: 107-112.
10. Gozes I, Brenneman DE. Neuropeptides as growth and differentation factors in general and VIP in particular. J Mol Neurosci 1993; 4: 1-9.
11. Gressens P, Hill JM, Gozes I, Fridkin M, Brenneman DE. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature 1993; 362: 155-158.
12. Muller JM, Lelievre V, Becq-Giraudon L, Meunier AC. VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment. Mol Neurobiol 1995; 10: 115-134.
13. Rawlings SR. PACAP, PACAP receptors, and intracellular signalling. Mol Cell Endocrinol 1994; 101: C5-C9.
14. Bellot F, Pichon J, Luis J et al. Extracellular material secreted by human colonic adenocarcinoma cell lines (HT29 and HRT18) promotes their own very rapid spreading in serum free medium and induces neurite outgrowth of PC 12 cells. Int J Cancer 1985; 36: 609-615.
15. 17]-Vasoactive intestinal polypeptide. J Biol Chem 1986; 261: 5320-5327.
16. Muller JM, Battari AE, Ah-Kye E. Internalization of the vasoactive intestinal peptide (VIP) in a human adenocarcinoma cell line (HT29). Eur J Biochem 1985; 152: 107-114.
17. Muller JM, Luis J, Fantini J. Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT29). Eur J Biochem 1985; 151: 411-417
18. Pence JC, Shorter NA. In vitro differentiation of human neuroblastoma cells caused by vasoactive intestinal peptide. Cancer Res 1990; 50: 5177-5183.
19. Pincus DW, DiCicco-Bloom EM, Black IB. Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature 1990; 343: 564-567.
20. O'Dorisio MS, Fleshman DJ, Qualman SJ, O'Dorisio TM. Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma. Reg Peptides 1992; 37: 213-226.
21. Okumura N, Miyatake Y, Takao T et al. Vasoactive intestinal peptide induces differentiation and MAP kinase activation in PC12h cells. J Biochem 1994; 115: 304-308.
22. Yu D, Seitz PK, Selvanayagam P, Rajaraman S, Townsend CM Jr, Cooper CW. Effects of vasoactive intestinal peptide on adenosine 3′5′-monophosphate, ornithine decarboxylase and cell growth in a human colon cell line. Endocrinology 1992; 131: 1188-1194.
23. Hill JM, Agoston DV, Gressens P, McCune SK. Distribution of VIP mRNA and two distinct VIP binding sites in the developing rat brain: Relation to ontogenic events. J Comparative Neurol 1994; 342: 186-205.